Page 5 - Read Online

Hepatoma Research

C O NT E NT S

Topic: Immunotherapy and Immunotherapy Biomarkers for Hepatocellular Carcinoma

Review
1 Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
Cecilia Monge Bonilla, Nicole A. McGrath, Jianyang Fu, Changqing Xie
Hepatoma Res 2020;6:68. https://doi.org/10.20517/2394-5079.2020.58

2 The immune microenvironment and progression of immunotherapy and combination therapeutic
strategies for hepatocellular carcinoma
Zun-Yong Feng, Fang-Gui Xu, Yu Liu, Hao-Jun Xu, Fu-Bing Wu, Xiao-Bing Chen, Hong-Ping Xia
Hepatoma Res 2021;7:3. https://doi.org/10.20517/2394-5079.2020.107

3 Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms
and biomarkers
Sandi A. Kwee, Maarit Tiirikainen
Hepatoma Res 2021;7:8. https://doi.org/10.20517/2394-5079.2020.124

4 Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma
Samantha Armstrong, Petra Prins, Aiwu Ruth He
Hepatoma Res 2021;7:18. https://doi.org/10.20517/2394-5079.2020.118

Editorial
5 Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities
Sandi Kwee, Xin Chen
Hepatoma Res 2022;8:32. https://doi.org/10.20517/2394-5079.2022.58

Hepatoma Research III